Jillian B. Thomsen Insider Trading $NKTR NEKTAR THERAPEUTICS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jillian B. Thomsen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jillian B. Thomsen. Jillian B. Thomsen is SVP & Chief Accounting Officer in NEKTAR THERAPEUTICS ($NKTR) and VP & Chief Accounting Officer in NEKTAR THERAPEUTICS ($NKTR).
Jillian B. Thomsen in NEKTAR THERAPEUTICS
Trading Symbol: NKTRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jillian B. Thomsen: SVP & Chief Accounting Officer, VP & Chief Accounting Officer
Holdings: 164,552 shares
Current Value: $2,167,150
Latest Transaction: Feb 18 2021
$NKTR Market Capitalization: $2.01B
$NKTR Previous Close: $13.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jillian B. Thomsen in NEKTAR THERAPEUTICS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 22.37 | 11,705 | 261,841 | 164,552 | 176.3 K to 164.6 K (-6.64 %) |
Jan 29 2021 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 8.80 | 37,500 | 330,000 | 0 | |
Jan 29 2021 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 8.80 | 37,500 | 330,000 | 0 | |
Jan 29 2021 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 18.62 | 75,000 | 1,396,500 | 176,257 | 251.3 K to 176.3 K (-29.85 %) |
Jan 29 2021 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 8.80 | 37,500 | 330,000 | 251,257 | 213.8 K to 251.3 K (+17.54 %) |
Jan 29 2021 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 8.80 | 37,500 | 330,000 | 213,757 | 176.3 K to 213.8 K (+21.28 %) |
Dec 22 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 18.75 | 28,600 | 536,250 | 28,600 | |
Dec 22 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 16,000 | 0 | 176,257 | 160.3 K to 176.3 K (+9.98 %) |
Aug 19 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 19.67 | 1,367 | 26,889 | 171,733 | 173.1 K to 171.7 K (-0.79 %) |
May 20 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 22.51 | 1,367 | 30,771 | 172,719 | 174.1 K to 172.7 K (-0.79 %) |
Feb 20 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 22.35 | 1,394 | 31,156 | 174,086 | 175.5 K to 174.1 K (-0.79 %) |
Feb 07 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 7.21 | 37,500 | 270,375 | 0 | |
Feb 07 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 22.78 | 37,500 | 854,250 | 175,480 | 213 K to 175.5 K (-17.61 %) |
Feb 07 2020 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 7.21 | 37,500 | 270,375 | 212,980 | 175.5 K to 213 K (+21.37 %) |
Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 21.79 | 11,800 | 257,122 | 11,800 | |
Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 21.79 | 26,600 | 579,614 | 26,600 | |
Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 14,900 | 0 | 175,480 | 160.6 K to 175.5 K (+9.28 %) |
Nov 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 17.97 | 2,713 | 48,753 | 160,441 | 163.2 K to 160.4 K (-1.66 %) |
Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 18.15 | 1,809 | 32,833 | 163,154 | 165 K to 163.2 K (-1.10 %) |
May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 31.37 | 1,928 | 60,481 | 164,463 | 166.4 K to 164.5 K (-1.16 %) |
Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 42.39 | 1,808 | 76,641 | 166,391 | 168.2 K to 166.4 K (-1.07 %) |
Feb 06 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 10.69 | 16,119 | 172,312 | 0 | |
Feb 06 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 42.16 | 16,119 | 679,577 | 168,199 | 184.3 K to 168.2 K (-8.75 %) |
Feb 06 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 10.69 | 16,119 | 172,312 | 184,318 | 168.2 K to 184.3 K (+9.58 %) |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 36.51 | 22,150 | 808,697 | 22,150 | |
Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 10,950 | 0 | 168,199 | 157.2 K to 168.2 K (+6.96 %) |
Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 38.25 | 4,016 | 153,612 | 157,249 | 161.3 K to 157.2 K (-2.49 %) |
Nov 05 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 90,000 | 0 | 161,265 | 71.3 K to 161.3 K (+126.29 %) |
Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 56.90 | 26,250 | 1,493,625 | 26,250 | |
Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 56.90 | 26,250 | 1,493,625 | 26,250 | |
Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | D | 58.40 | 4,883 | 285,167 | 71,265 | 76.1 K to 71.3 K (-6.41 %) |
Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | D | 58.40 | 4,883 | 285,167 | 71,265 | 76.1 K to 71.3 K (-6.41 %) |
Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 10,400 | 0 | 76,148 | 65.7 K to 76.1 K (+15.82 %) |
Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 10,400 | 0 | 76,148 | 65.7 K to 76.1 K (+15.82 %) |
May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 83.39 | 3,576 | 298,203 | 65,281 | 68.9 K to 65.3 K (-5.19 %) |
Apr 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 10.69 | 13,881 | 148,388 | 16,119 | |
Apr 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 101.46 | 13,881 | 1,408,366 | 68,857 | 82.7 K to 68.9 K (-16.78 %) |
Apr 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 10.69 | 13,881 | 148,388 | 82,738 | 68.9 K to 82.7 K (+20.16 %) |
Feb 20 2018 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 82.94 | 2,545 | 211,082 | 68,857 | 71.4 K to 68.9 K (-3.56 %) |
Dec 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 56.90 | 26,250 | 1,493,625 | 26,250 | |
Dec 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 10,400 | 0 | 71,402 | 61 K to 71.4 K (+17.05 %) |
Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 14.41 | 37,500 | 540,375 | 37,500 | |
Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | D | 44.23 | 5,289 | 233,932 | 60,549 | 65.8 K to 60.5 K (-8.03 %) |
Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 15,000 | 0 | 65,838 | 50.8 K to 65.8 K (+29.51 %) |
Aug 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 19.32 | 2,648 | 51,159 | 50,838 | 53.5 K to 50.8 K (-4.95 %) |
May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 19.55 | 2,651 | 51,827 | 52,986 | 55.6 K to 53 K (-4.76 %) |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 7.21 | 37,500 | 270,375 | 0 | |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 11.34 | 75,000 | 850,500 | 0 | |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 19.69 | 112,500 | 2,215,125 | 55,637 | 168.1 K to 55.6 K (-66.91 %) |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 7.21 | 37,500 | 270,375 | 168,137 | 130.6 K to 168.1 K (+28.71 %) |
Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 11.34 | 75,000 | 850,500 | 130,637 | 55.6 K to 130.6 K (+134.80 %) |
Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.14 | 1,965 | 25,820 | 55,637 | 57.6 K to 55.6 K (-3.41 %) |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 12.24 | 37,500 | 459,000 | 37,500 | |
Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 15,000 | 0 | 57,602 | 42.6 K to 57.6 K (+35.21 %) |
Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.96 | 1,986 | 27,725 | 42,102 | 44.1 K to 42.1 K (-4.50 %) |
Aug 17 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 17.56 | 3,971 | 69,731 | 44,088 | 48.1 K to 44.1 K (-8.26 %) |
Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 15.55 | 18,750 | 291,563 | 18,750 | |
Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 22,500 | 0 | 29,309 | 6.8 K to 29.3 K (+330.44 %) |
Jul 13 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 4.65 | 100,000 | 465,000 | 0 | |
Jul 13 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 15.09 | 100,000 | 1,509,000 | 6,809 | 106.8 K to 6.8 K (-93.63 %) |
Jul 13 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 4.65 | 100,000 | 465,000 | 106,809 | 6.8 K to 106.8 K (+1,468.64 %) |
May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | D | 0.00 | 1,875 | 0 | 18,750 | |
May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.58 | 724 | 9,832 | 6,309 | 7 K to 6.3 K (-10.29 %) |
May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 0.00 | 1,875 | 0 | 7,033 | 5.2 K to 7 K (+36.35 %) |
Mar 11 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 0 | |
Mar 11 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 11.79 | 15,000 | 176,850 | 5,158 | 20.2 K to 5.2 K (-74.41 %) |
Mar 11 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 20,158 | 5.2 K to 20.2 K (+290.81 %) |
Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | D | 0.00 | 1,875 | 0 | 20,625 | |
Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 11.92 | 716 | 8,535 | 5,158 | 5.9 K to 5.2 K (-12.19 %) |
Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 0.00 | 1,875 | 0 | 5,874 | 4 K to 5.9 K (+46.89 %) |
Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 15,000 | |
Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 11.49 | 15,000 | 172,350 | 3,999 | 19 K to 4 K (-78.95 %) |
Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,999 | 4 K to 19 K (+375.09 %) |
Jan 21 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 30,000 | |
Jan 21 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 14.12 | 15,000 | 211,800 | 3,999 | 19 K to 4 K (-78.95 %) |
Jan 21 2016 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,999 | 4 K to 19 K (+375.09 %) |
Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 15.55 | 22,500 | 349,875 | 22,500 | |
Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 0.00 | 18,750 | 0 | 18,750 | |
Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 45,000 | |
Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 15.87 | 15,000 | 238,050 | 3,999 | 19 K to 4 K (-78.95 %) |
Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,999 | 4 K to 19 K (+375.09 %) |
Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 60,000 | |
Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.52 | 15,000 | 202,800 | 3,499 | 18.5 K to 3.5 K (-81.09 %) |
Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,499 | 3.5 K to 18.5 K (+428.69 %) |
Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 75,000 | |
Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 10.99 | 15,000 | 164,850 | 3,499 | 18.5 K to 3.5 K (-81.09 %) |
Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,499 | 3.5 K to 18.5 K (+428.69 %) |
Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 10,000 | 66,500 | 90,000 | |
Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.04 | 10,000 | 130,400 | 3,499 | 13.5 K to 3.5 K (-74.08 %) |
Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 10,000 | 66,500 | 13,499 | 3.5 K to 13.5 K (+285.80 %) |
Feb 10 2011 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 10.69 | 30,000 | 320,700 | 30,000 | |
Feb 03 2010 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 11.34 | 75,000 | 850,500 | 75,000 | |
May 14 2009 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | M | 0.00 | 550 | 0 | 550 | |
May 14 2009 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Sell | S | 5.57 | 201 | 1,120 | 1,951 | 2.2 K to 2 K (-9.34 %) |
May 14 2009 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Buy | M | 0.00 | 550 | 0 | 2,152 | 1.6 K to 2.2 K (+34.33 %) |
Feb 25 2009 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | A | 4.65 | 100,000 | 465,000 | 100,000 | |
Nov 18 2008 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Option Exercise | M | 0.00 | 567 | 0 | 1,134 | |
Nov 18 2008 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Sell | S | 4.37 | 203 | 887 | 1,602 | 1.8 K to 1.6 K (-11.25 %) |
Nov 18 2008 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | VP & Chief Accounti ... | Buy | M | 0.00 | 567 | 0 | 1,805 | 1.2 K to 1.8 K (+45.80 %) |
Page: 1